WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 212
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 252

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported case

(Click for retrospective incidence data for Niue)
Diphtheria
Japanese encephalitis
Measles 22 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Niue)
Vaccine year result method % card seen                                                
BCG          99*  99*  99*  99*  99* 
DTP1          99*  99*  99*  99*  99* 
DTP3          99*  99  99  99*  99* 
DTP4         
IPV1         
HepB_BD          99*  99*  99*  55  99* 
HepB3          99*  99  99  99*  99* 
Hib3          99*  99  99  99*  99* 
JapEnc         
MCV1          99*  99*  99*  99*  99* 
MCV2          99*  98  98  99*  99* 
PCV1          99*  99*  99  99* 
PCV3          99*  99  99  99* 
Pol3          99*  99  99  99*  99* 
Rota1         
Rota_last         
Rubella1          99*  99*  99*  99* 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Niue)
BCG 99  99  99  99  99  99  99  85 
DTP1 99  99  99  99  99  99  99  27 
DTP3 99  99  98  98  99  99  99 
HepB3 99  99  98  98  99  99 
HepB_BD 99  99  99  99  55  99 
Hib3 99  99  99  99  99  99 
MCV1 99  99  99  99  99  99  99  77 
MCV2 99  99  98  98  99  99 
PCV3 99  99  99  99  99 
Pol3 99  99  98  98  99  99  99  76 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepIPV 6 weeks; 3, 5 months; Yes
DTaPIPV 4 years; Yes
DTwPIPV 4 years;
HIB 15 months; Yes
HepB Birth; 6 weeks; 3, 5 months; Yes
Influenza 65 years;
MMR 15 months; 4 years; Yes
Pneumo_conj 6 weeks; 3, 5, 15 months; Yes
Td 11 years;

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR   No  Yes  Yes  Yes  Yes   
What years does the MYP cover? number         Annual  2'009  2'019 
Nº of districts with microplans that include activities to raise immunization coverage number   NA 

System performance

Total Nº districts in country number  
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100%   100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100%   100  100  100  100  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND   Yes  Yes  Yes  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR   No  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%       100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR   Yes  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.